<b>Conclusions:</b> This study integrates network pharmacology with single-cell and experimental approaches to demonstrate that XAFHO exerts multi-target and multi-cell anti-cervical cancer effects, potentially by modulating lipid metabolism and immune-related pathways via <i>FASN</i> and <i>SPP1</i>. The gene discussed is SPP1; the disease is cervical carcinoma.